TickerTalks
Browse all tickers →
TickerTalks›$STE
STSTE

STERIS plc

$STE·$23B·Medical - Specialties·Healthcare
$231.46-0.5%
Mentions · last 7 days
2026-07-30: 1 posts2026-07-31: 2 posts2026-08-01: 1 posts2026-08-02: 1 posts2026-08-03: 0 posts2026-08-04: 13 posts2026-08-05: 16 posts34
Price updated 10m ago·X counts updated 22h ago
STSTE
$STESTERIS plc
$231.46-0.54%34 posts
AI analysisFundamentalsVoices on X
Loading…

What it does

Plain-English summary of the business — what they sell and how they make money.

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Specialties sits in its cycle right now — and what that implies for $STE.

Medical - Specialties · Healthcare

Ekso Bionics' exoskeleton technology for rehabilitation and worker ergonomics is the sole narrative here — reimbursement coverage expansion is the key gating catalyst for hospital adoption, with commercial leadership team appointments indicating management prioritization of growth acceleration.

Top industry ETF

$XLVHealth Care Select Sector SPDR
+4.7%YTD
+23.9%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
29.3How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
8.5%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
18.6%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
4.3%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
3.8Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
11.1%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
44.2%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.3Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 5, 2026$2.59$2.49+4.0%
Q1 2026May 11, 2026$2.83$2.85-0.7%
Q4 2025Feb 4, 2026$2.53$2.530.0%
Q3 2025Nov 5, 2025$2.47$2.35+5.1%

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q1 FY27$1.5B+7.3%45.8%19.1%$2.05$279.6M
Q4 FY26$1.6B+7.3%43.9%19.9%$2.24$245.2M
Q3 FY26$1.5B+9.2%43.8%18.1%$1.96$199.5M
Q2 FY26$1.5B+9.9%44.2%18.4%$1.95$201.3M

Forward consensus

4-year forecast · up to 6 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$5.9B$5.9B – $6.0B$10.20$10.19 – $10.216
FY27$6.4B$6.4B – $6.4B$11.16$11.15 – $11.216
FY28$6.8B$6.8B – $6.8B$12.18$11.85 – $12.526
FY29$7.2B$7.2B – $7.2B$13.20$12.05 – $15.243

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1.2×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.51%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+8.6%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-0.7%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatMid float · 97.1M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.9% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.925-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

SellJun 15Zangerle John AdamSr. VP, Gen Counsel, and Sec.1.4K sh$297KSellJun 5Daniel A CarestioCEO1.4K sh$291KSellJun 4Daniel A CarestioCEO3.1K sh$656KSellJun 2Richard C BreedenDirector1.5K sh$310K
+ 36 other (23 inkinds · 10 awards · 3 exempts) in window

See when $STE insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KRestructuring / exit costsAug 58-K — Item 2.02: Earnings release · Item 2.05: Restructuring / exit costs
3New insider — initial holdingsMay 143
8-KOfficer or director changeMay 78-K — Item 5.02: Officer or director change · Item 7.01: Press release / Reg FD
8-KOfficer or director changeApr 68-K — Item 5.02: Officer or director change
+ 11 other (4 13Gs · 2 proxys · 1 11-K · 1 ARS) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Here's What Key Metrics Tell Us About Steris (STE) Q1 Earningszacks.com·1d agoSteris (STE) Q1 Earnings Surpass Estimateszacks.com·1d agoSTERIS Announces Financial Results for Fiscal 2027 First Quarterglobenewswire.com·1d agoSteris to invest $600 million in new North Carolina chemicals manufacturing hubreuters.com·1d agoSTERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolinaglobenewswire.com·2d ago
Voices on X · last 7 days

No standout posts about $STE on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport